LOS ANGELES, May 2, 2017 /PRNewswire/ -- Global Health Solutions, a leader in innovative solutions for acute and chronicwound care, has announced filing of its first 510(k) application for dermatologic indications. Global Health Solutions' signature petrolatum-based wound formula, used every day in leading clinics and institutions, has shown incredible promise in managing
Global Health Solutions founder and CEO, Bradley Burnam, states: "As a company, we take our cues from practitioners, who have provided consistent feedback regarding the technology's ability to manage or eliminate symptoms of these dermatoses. Patients who wish to avoid the side-effects of steroidal products will soon have an option that not only soothes symptoms without irritating, but addresses the lack of natural antimicrobials known to plague the skin of eczema sufferers. We are extremely excited to work with FDA on this important filing and hope for an expeditious process. As we continue to gather data, additional filings in post-surgical care, onychomycosis, and infection control will follow in rapid succession."
Global Health Solutions, LLC, is a concept-to-approval research, development, and commercialization entity focused on novel, best in class products for infection control, skin, and wound care. The company's proprietary technologies are used every day by world-leading healthcare institutions to care for a variety of skin and wound conditions. For more information, including contact forms, visit www.globalhealthrx.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-health-solutions-announces-filing-of-510k-application-for-fda-clearance-of-non-steroidal-eczema-formula-300449817.html
SOURCE Global Health Solutions
Subscribe to our Free Newsletters!
Strokes occur when blood flow to an area of the brain is cut off. It is imperitive to detect the ...
Bile duct cancer occurs either within the liver or the point where the bile ducts emerge from the ...
Xeroderma pigmentosum is a rare inherited condition marked by extreme sensitivity to sunlight and ...View All